Common GHRPs include: Alexamorelin GHRP-1 GHRP-2 GHRP-3 GHRP-4 GHRP-5 GHRP-6 Hexarelin Potential benefits include: Increased growth hormone release Higher IGF-1 levels Improved recovery Increased appetite (especially GHRP-6) In research conducted on healthy adults, GHRP-2 infusion caused significant increases in serum growth hormone levels and stimulated food intake, with participants eating about 35 percent to 36 percent more calories compared with saline, demonstrating both increased GH secretion and appetite stimulation
GLP-1R/GIPR agonist-1 sodium reduces food intake, inhibits weight gain, repairs islet damage, improves glucose tolerance, regulates serum lipid and liver enzyme levels, ameliorates hepatic vacuolization, reduces hepatic fat accumulation, delays the progression of hepatic fibrosis, and exhibits long-lasting hypoglycemic activity
Obesity Canada puts the cost of not treating obesity at $27.6 billion annually
However, individual factors like metabolism and adherence to treatment can influence effectiveness
Rita Cardoso B, Apolinario D, da Silva Bandeira V, Busse AL, Magaldi RM, Jacob-Filho W et al